Literature DB >> 19096916

Presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) in ameloblastomas correlate with rupture of the osseous cortical.

Eduardo Rodrigues Fregnani1, Lays M Sobral, Fabio Abreu Alves, Fernando Augusto Soares, Luis Paulo Kowalski, Ricardo D Coletta.   

Abstract

Myofibroblasts are frequent in the stroma of neoplasm and by the expression of proteinases they can influence tumor infiltration and progression. In the present study, presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) and urokinase plasminogen activator (uPA) were examined in intra-osseous solid multicystic ameloblastomas to determine their roles in the clinicopathological features of the tumors. Fifty seven ameloblastomas were analyzed immunohistochemically with antibodies against the isoform alpha of the smooth muscle actin (alpha-SMA), a specific marker of myofibroblasts, MMP-2 and uPA. Myofibroblasts were found in the stroma, in close contact with neoplastic cell islands, of approximately 58% (n = 33) of the ameloblastomas. MMP-2 and uPA were found in the cytoplasm of both neoplastic and stromal cells. A significant correlation between presence of myofibroblasts and MMP-2 expression was observed. Abundant presence of myofibroblast in the stroma of the tumors and expression of MMP-2 in the neoplastic or stromal cells were significantly correlated with rupture of the osseous cortical, which has been considered an important prognostic marker of ameloblastoma aggressiveness. Ours results suggest that abundant presence of myofibroblasts and expression of MMP-2 in solid ameloblastomas may be associated with a more aggressive infiltrative behavior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19096916     DOI: 10.1007/s12253-008-9110-4

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  52 in total

Review 1.  Molecular targets in pulmonary fibrosis: the myofibroblast in focus.

Authors:  Chris J Scotton; Rachel C Chambers
Journal:  Chest       Date:  2007-10       Impact factor: 9.410

Review 2.  The ameloblastoma: primary, curative surgical management.

Authors:  Eric R Carlson; Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2006-03       Impact factor: 1.895

3.  Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.

Authors:  Audrey M Bernstein; Sally S Twining; Debra J Warejcka; Edward Tall; Sandra K Masur
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

4.  Urokinase plasminogen activator in injured adventitia increases the number of myofibroblasts and augments early proliferation.

Authors:  Olga S Plekhanova; Victoria V Stepanova; Elizaveta I Ratner; Alex Bobik; Vsevolod A Tkachuk; Yelena V Parfyonova
Journal:  J Vasc Res       Date:  2006-08-07       Impact factor: 1.934

5.  Mutual paracrine effects of colorectal tumour cells and stromal cells: modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture.

Authors:  Sydney Mukaratirwa; Jos F Koninkx; Erik Gruys; Hubertus Nederbragt
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

6.  Dense fibrillar collagen matrices: a model to study myofibroblast behaviour during wound healing.

Authors:  Christophe Helary; Ludmila Ovtracht; Bernard Coulomb; Gaston Godeau; Marie Madeleine Giraud-Guille
Journal:  Biomaterials       Date:  2006-05-05       Impact factor: 12.479

7.  Management of mandibular ameloblastoma: the clinical basis for a treatment algorithm.

Authors:  D E Sampson; M A Pogrel
Journal:  J Oral Maxillofac Surg       Date:  1999-09       Impact factor: 1.895

8.  Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.

Authors:  Piotr Czochra; Borut Klopcic; Erik Meyer; Johannes Herkel; Jose Francisco Garcia-Lazaro; Florian Thieringer; Peter Schirmacher; Stefan Biesterfeld; Peter R Galle; Ansgar W Lohse; Stephan Kanzler
Journal:  J Hepatol       Date:  2006-05-30       Impact factor: 25.083

9.  The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.

Authors:  Birgitte Vrou Offersen; Boye Schnack Nielsen; Gunilla Høyer-Hansen; Fritz Rank; Stephen Hamilton-Dutoit; Jens Overgaard; Peter A Andreasen
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  Prostaglandin I2 analog enhances the expression of urokinase-type plasminogen activator and wound healing in cultured human fibroblast.

Authors:  T Hatane; E Yoshida; J Kawano; M Sugiki; T Onitsuka; M Maruyama
Journal:  Biochim Biophys Acta       Date:  1998-06-22
View more
  9 in total

1.  Comparison of Myofibroblasts Between Solid/Multicystic Ameloblastoma and Unicystic Ameloblastoma: An Immunohistochemical Analysis.

Authors:  Gowdara Prakash Smitha; Sadhana Shenoy; Thondikulam Venakataraman Narayan; Ranjita Jayaram
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma.

Authors:  Marina Rolo Pinheiro da Rosa; Aline Semblano Carreira Falcão; Hellen Thais Fuzii; Maria Sueli da Silva Kataoka; André L R Ribeiro; Enrique Boccardo; Adriane Sousa de Siqueira; Ruy G Jaeger; João de Jesus Viana Pinheiro; Sérgio de Melo Alves Júnior
Journal:  Tumour Biol       Date:  2014-08-07

Review 3.  Myofibroblasts in oral lesions: A review.

Authors:  Soujanya Pinisetti; Ravikanth Manyam; Babburi Suresh; V Aparna
Journal:  J Oral Maxillofac Pathol       Date:  2014-01

Review 4.  Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update.

Authors:  Ravleen Nagi; Shashikant Sahu; N Rakesh
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

5.  Immunohistochemical study of alpha-smooth muscle actin in odontogenic cysts and tumors.

Authors:  Vidya Mallipattana Annegowda; Hs Uma Devi; Kavita Rao; T Smitha; H S Sheethal; A Smitha
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug

6.  Molecular markers of tumor invasiveness in ameloblastoma: An update.

Authors:  Yi Zhong; Wei Guo; Li Wang; Xinming Chen
Journal:  Ann Maxillofac Surg       Date:  2011-07

7.  Immunohistochemical evaluation of myofibroblast density in odontogenic cysts and tumors.

Authors:  Maryam Kouhsoltani; Monireh Halimi; Golchin Jabbari
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2016-03-16

8.  Immunohistochemical Expression of Myofibroblasts Using Alpha-smooth Muscle Actin (SMA) to Assess the Aggressive Potential of Various Clinical Subtypes of Ameloblastoma.

Authors:  Uma Mudaliar; Avinash Tamgadge; Sandhya Tamgadge; Treville Pereira; Snehal Dhouskar; Sonali Rajhans; Gourav Salunke
Journal:  J Microsc Ultrastruct       Date:  2019 Jul-Sep

9.  Immunohistochemical and clinical significance of matrix metalloproteinase-2 and its inhibitor in oral lichen planus.

Authors:  Neha Agarwal; Sunitha Carnelio; Gabriel Rodrigues
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.